Eczema: all 1,088 studies

Page 6 of 11. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.

• An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne OutcomesWithdrawnNCT05873933Not applicable
• Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic DermatitisCompletedNCT05844618Phase 4
• A First-in-Human Study of QY211 Gel in Adult SubjectsStatus unknownNCT05843422Phase 1
• Use of Complementary and Alternative Medicine in Children and Adults With Atopic DermatitisCompletedNCT05833880
• Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic EczemaStatus unknownNCT05790083Not applicable
• CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTSCompletedNCT05783453
• The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and PsoriasisCompletedNCT05770271Not applicable
• A Study of Hemay005 in Adult With Atopic DermatitisCompletedNCT05769946Phase 2
• Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe XerosisCompletedNCT05765461
• A 24-week Single-blind Trial of Prevention of Hand Eczema in CleanersCompletedNCT05763914Not applicable
• The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical TrialStatus unknownNCT05719649Not applicable
• A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)CompletedNCT05717920Phase 2
• Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT05715320Phase 2
• Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment ResponseStatus unknownNCT05692843Phase 4
• Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in ChinaCompletedNCT05680298Phase 4
• The Study of CM326 in Adult Subjects With Atopic DermatitisStatus unknownNCT05671445Phase 2
• The Study of CM326 in Moderate-to-severe Atopic DermatitisStatus unknownNCT05671432Phase 2
• An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real WorldActive, not recruitingNCT05669794
• Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food AllergyStatus unknownNCT05662800
• To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with ADCompletedNCT05650320Phase 3
• Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic DermatitisCompletedNCT05644691
• CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic DermatitisWithdrawnNCT05614817Phase 3
• This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)CompletedNCT05608343Phase 3
• GB-EZ-SIM03 Probiotics Study for Childhood EczemaCompletedNCT05607511Not applicable
• Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With DupilumabCompletedNCT05602207Phase 4
• The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape StripsStatus unknownNCT05598762Not applicable
• Atopic Dermatitis With Accelerometry and Polysomnography (ADAP)CompletedNCT05583019
• A Study of CM310 in Children Patients With Moderate-to-severe Atopic DermatisCompletedNCT05579925Phase 2
• Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic DermatitisStatus unknownNCT05578482Phase 4
• A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic DermatitisCompletedNCT05571943Phase 3
• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisActive, not recruitingNCT05559359Phase 3
• Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand EczemaWithdrawnNCT05545215
• Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral EczemaCompletedNCT05540496
• Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic DermatitisCompletedNCT05531188
• Therapist-guided vs Self-guided CBT for AD: Non-inferiority TrialCompletedNCT05517850Not applicable
• Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)Active, not recruitingNCT05509023Phase 2
• Targeting Staphylococci in Atopic DermatitisStatus unknownNCT05502185
• A Clinical Trial of BMX-010 in Adult Subjects With Atopic DermatitisTerminatedNCT05491447Phase 2
• Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic DermatitisCompletedNCT05487963Phase 1/2
• Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand EczemaCompletedNCT05486117Phase 1
• Clinical Relevance of Scratching and Sleep in Atopic DermatitisCompletedNCT05467046
• A Study of MG-K10 in Subjects With Atopic DermatitisActive, not recruitingNCT05466877Phase 2
• Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%CompletedNCT05461456Phase 1
• A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.CompletedNCT05454722Not applicable
• A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in TaiwanCompletedNCT05442645
• A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With EczemaStatus unknownNCT05439577
• Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic DermatitisStatus unknownNCT05437887Not applicable
• Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisCompletedNCT05432596Phase 2
• Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)Status unknownNCT05413395Not applicable
• A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.Active, not recruitingNCT05387980
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic DermatitisTerminatedNCT05387707Phase 3
• A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic DermatitisCompletedNCT05383378Phase 1
• A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic DermatitisTerminatedNCT05382819Phase 1
• IL-4 and Insulin Resistance for Treatment of Patients With Atopic DermatitisCompletedNCT05372003Early Phase 1
• Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic DermatitisStatus unknownNCT05326672Phase 3
• Evaluation of an Adapted Formula on Atopic Dermatitis.Active, not recruitingNCT05318300Not applicable
• Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children StudyCompletedNCT05276323Phase 2
• A Study of CM310 in Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05265923Phase 3
• Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.Status unknownNCT05265234Phase 4
• Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2WithdrawnNCT05233410Phase 3
• A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin AreaCompletedNCT05226143Not applicable
• Immunomodulation by OM-85 (Broncho-Vaxom) in Early ADTerminatedNCT05222516Phase 2
• Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1WithdrawnNCT05219864Phase 3
• A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf CountriesCompletedNCT05214326
• Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT05203380
• The Study of CM326 in Patients With Moderate-to-severe Atopic DermatitisStatus unknownNCT05186922Phase 1/2
• Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic DermatitisCompletedNCT05158023Phase 2
• Scratching Validation StudyCompletedNCT05137093
• Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic DermatitisStatus unknownNCT05136261Phase 3
• SkIN hydrAtion Evaluation With TeRAhertz ScanningCompletedNCT05121207Not applicable
• Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic DermatitisStatus unknownNCT05092464Not applicable
• Creation of a Shared Medical Decision-making Tool for Atopic DermatitisStatus unknownNCT05090982
• The Role of Genetic Factors in the Development of Atopic Dermatitis in the Kazakh PopulationCompletedNCT05090631
• A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.CompletedNCT05062213Not applicable
• Evaluate Efficacy of FB825 in Adults With Atopic DermatitisCompletedNCT05059509Phase 2
• A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic DermatitisCompletedNCT05057351Not applicable
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically AdvisableWithdrawnNCT05056779Phase 3
• RCT to Evaluate the Cosmetic Efficacy of Demo-cosmetic Active Ingredient CLS02021CompletedNCT05048121Not applicable
• Study of Ruxolitinib Cream in Children With Atopic DermatitisCompletedNCT05034822Phase 1
• Assessing SleeP IN Infants With Atopic Dermatitis by Longitudinal EvaluationStatus unknownNCT05031754
• China Atopic Dermatitis Registry StudyStatus unknownNCT05023668
• Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis PatientsCompletedNCT05019209Not applicable
• Comparison of JW-100 and EUCRISA for the Treatment of Atopic DermatitisWithdrawnNCT05016284Phase 3
• Evaluation of the Efficacy of Topialyse Baume barrière on Atopic DermatisWithdrawnNCT05006300Not applicable
• Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)Status unknownNCT05004324Phase 3
• The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of EczemaCompletedNCT05003453Phase 2/3
• Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood EczemaCompletedNCT04986384Not applicable
• Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic DermatitisCompletedNCT04976868
• Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant PhenotypesWithdrawnNCT04965233
• Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic DermatitisTerminatedNCT04955951
• A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.WithdrawnNCT04950374Not applicable
• Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 StudyTerminatedNCT04936113Phase 2
• Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic DermatitisCompletedNCT04927572Phase 1/2
• Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild AsthmaCompletedNCT04927195Phase 1
• Acceptance and Commitment Therapy-based Eczema Management ProgrammeCompletedNCT04919330Not applicable
• Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of LifeCompletedNCT04900948Phase 4
• Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in ChildhoodStatus unknownNCT04895423Phase 4
• Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04893941Phase 1/2
• The Study of CM310 in Patients With Atopic DermatitisCompletedNCT04893707Phase 2
• Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT04875169Phase 3

← Eczema overview